Provides relative to disclosure by healthcare facilities to patients of prices for certain items and services (EN GF EX See Note)
Provides relative to the regulation of consumable hemp products (EG INCREASE SG RV See Note)
Provides relative to disclosure by healthcare facilities to patients of prices for certain items and services (OR INCREASE GF EX See Note)
Provides relative to kratom products (OR SEE FISC NOTE SG EX)
Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)
Provides for the termination of certain tax exemptions, exclusions, credits, deductions, and other tax incentives (EG INCREASE GF RV See Note)
Provides relative to medicaid coverage of chimeric antigen receptor T-cell therapy (EN SEE FISC NOTE GF EX See Note)
Provides relative to sales and use taxation of certain digital products and services (EG INCREASE GF RV See Note)
Provides relative to industrial hemp. (gov sig) (EG1 INCREASE GF EX See Note)
Provides relative to the regulation of cannabis (OR INCREASE SG EX See Note)